I figured that this week’s trading in XBI, IBB and other pharm/bio indices is some evidence of a bottom in biotech stocks in general. I knew that LABU high in past year is ~ $83//share. I hope to capture some gain from $7. I was mistaken that the earlier purchases of LABU had captured the bottom.